Thiard News@F4F

@newsen.bsky.social

1 week ago

Innocan Pharma Completes Additional Debenture Offering with Major Shareholder Innocan Pharma Corporation announces the successful closure of an additional debenture with its largest shareholder, Tamar Innovest, for $200,000.

Innocan Pharma Completes Additional Debenture Offering with Major Shareholder #Israel #Innocan_Pharma #Herzliya #Tamar_Innovest #Debenture

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Innocan Pharma Moves Forward with Significant Debenture Offering to Tamar Innovest Innocan Pharma announces a new debenture offering to Tamar Innovest, aiming for $200,000 in funding while bolstering its corporate structure.

Innocan Pharma Moves Forward with Significant Debenture Offering to Tamar Innovest #Innocan_Pharma #Tamar_Innovest #Debenture_Offering

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Innocan Pharma's 2025 Financial Results Reveal $26.6 Million Revenue Innocan Pharma has revealed its financial outcomes for 2025, with revenues reaching $26.6 million. The company focuses on innovative drug delivery technologies and wellness products.

Innocan Pharma's 2025 Financial Results Reveal $26.6 Million Revenue #Canada #Calgary #Innocan_Pharma #Chronic_Pain #LPT_Technology

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

Innocan Pharma Completes Debenture Offering to Tamar Innovest for Continued Growth Innocan Pharma has successfully closed a debenture deal with its main shareholder, Tamar Innovest. The funding of $450,000 is aimed at enhancing corporate operations and supporting its NYSE listing.

Innocan Pharma Completes Debenture Offering to Tamar Innovest for Continued Growth #Canada #Calgary #Innocan_Pharma #Tamar_Innovest #Debenture

Thiard News@F4F

@newsen.bsky.social

1 month ago

Innocan Pharma Announces Significant Debenture Offering to Major Shareholder Tamar Innovest Innocan Pharma is set to offer a debenture to Tamar Innovest, its largest shareholder, aiming to raise $450,000 with a 10% interest rate. This move supports the company’s capital and growth.

Innocan Pharma Announces Significant Debenture Offering to Major Shareholder Tamar Innovest #Canada #Calgary #Innocan_Pharma #Tamar_Innovest #Debenture

Thiard News@F4F

@newsen.bsky.social

1 month ago

Innocan Pharma Receives Third FDA Fee Waiver for Innovative Animal Drug Technology Innocan Pharma Corporation has achieved a third consecutive fee waiver from the FDA, enabling advancements in its innovative LPT-CBD product for chronic pain in dogs.

Innocan Pharma Receives Third FDA Fee Waiver for Innovative Animal Drug Technology #USA #Innocan_Pharma #LPT-CBD #FDA_Fee_Waiver #Herzliya,_Calgary

Thiard News@F4F

@newsen.bsky.social

2 months ago

Innocan Pharma's LPT-CBD Proves Effective in Pain Relief for Dogs, Surpassing Placebo Innocan Pharma has unveiled findings from a pivotal study showing its LPT-CBD's superior pain relief effects in dogs suffering from osteoarthritis compared to placebo.

Innocan Pharma's LPT-CBD Proves Effective in Pain Relief for Dogs, Surpassing Placebo #Canada #Calgary #Innocan_Pharma #LPT-CBD #CBD

Thiard News@F4F

@newsen.bsky.social

2 months ago

Innocan Pharma to List on NYSE American with Concurrent Offering Innocan Pharma Corporation announces plans for a listing on the NYSE American, coupled with a concurrent security offering, enhancing investor visibility.

Innocan Pharma to List on NYSE American with Concurrent Offering #USA #Calgary #pharmaceuticals #Innocan_Pharma #CBD_Delivery

Thiard News@F4F

@newsen.bsky.social

3 months ago

Innocan Pharma Corporation Sets Sights on NYSE American Listing and Concurrent Offering Innocan Pharma Corporation is preparing for its anticipated listing on the NYSE American, accompanied by a concurrent offering of its securities, marking an important milestone.

Innocan Pharma Corporation Sets Sights on NYSE American Listing and Concurrent Offering #None #Innocan_Pharma #CBD #Liposome

Thiard News@F4F

@newsen.bsky.social

4 months ago

Innocan Pharma Moves Forward with Amended Public Offering Plans in U.S. Innocan Pharma Corporation has made strides towards a public offering in the U.S. by filing an amended registration statement with the SEC, moving forward in the pharmaceutical sector.

Innocan Pharma Moves Forward with Amended Public Offering Plans in U.S. #USA #Calgary #Innocan_Pharma #LPT-CBD #SEC_Amendment

Thiard News@F4F

@newsen.bsky.social

4 months ago

Innocan Pharma's Q3 2025 Report Shows Resilience in Revenues with US$21.6M Innocan Pharma announces its financial results for Q3 2025, with revenues of US$21.6 million, showcasing continued resilience despite market challenges.

Innocan Pharma's Q3 2025 Report Shows Resilience in Revenues with US$21.6M #Israel #Innocan_Pharma #LPT-CBD #Herzliya #B.I._Sky_Global

Thiard News@F4F

@newsen.bsky.social

4 months ago

Innocan Pharma's Groundbreaking Study on Pain Relief Using LPT-CBD in Goats Shows Promising Results Innocan Pharma's recent study published in Frontiers in Pharmacology reveals promising results for LPT-CBD injections in goats, indicating potential for chronic pain relief.

Innocan Pharma's Groundbreaking Study on Pain Relief Using LPT-CBD in Goats Shows Promising Results #USA #Calgary #Innocan_Pharma #LPT-CBD #Chronic_Pain_Relief

Thiard News@F4F

@newsen.bsky.social

4 months ago

Innocan Pharma's Groundbreaking LPT-CBD Shows Promising Results in Pigs for Drug Development Innocan Pharma announces successful study results for LPT-CBD in Göttingen Minipigs, shedding light on drug safety and metabolism for future human applications.

Innocan Pharma's Groundbreaking LPT-CBD Shows Promising Results in Pigs for Drug Development #Canada #Calgary #Innocan_Pharma #LPT-CBD #Göttingen_Minipigs

Thiard News@F4F

@newsen.bsky.social

5 months ago

Innocan Pharma Set to Showcase Innovations at 2025 ThinkEquity Conference Innocan Pharma Corporation is thrilled to announce its participation in the 2025 ThinkEquity Conference, focusing on breakthroughs in pain management.

Innocan Pharma Set to Showcase Innovations at 2025 ThinkEquity Conference #USA #New_York_City #Innocan_Pharma #CBD_Technology #ThinkEquity

Thiard News@F4F

@newsen.bsky.social

5 months ago

Innocan Pharma Secures Patent for Innovative Liposomal CBD Injection in Japan Innocan Pharma's LPT-CBD patent has been allowed in Japan, marking a significant step toward non-opioid chronic pain management solutions.

Innocan Pharma Secures Patent for Innovative Liposomal CBD Injection in Japan #Japan #Tokyo #Innocan_Pharma #LPT-CBD #CBD_Technology

Thiard News@F4F

@newsen.bsky.social

6 months ago

Innocan Pharma Collaborates with Animal Sanctuary to Provide Pain Relief with LPT-CBD Injection Innocan Pharma is enhancing the lives of rescued animals through its collaboration with Freedom Farm, utilizing LPT-CBD injections for pain relief.

Innocan Pharma Collaborates with Animal Sanctuary to Provide Pain Relief with LPT-CBD Injection #USA #Calgary #Innocan_Pharma #LPT-CBD #Freedom_Farm

Thiard News@F4F

@newsen.bsky.social

6 months ago

Innocan Pharma's Innovative CBD Technology Captivates Audience at PAINWeek Conference Innocan Pharma's groundbreaking LPT-CBD technology drew significant attention at the PAINWeek conference, highlighting its potential for chronic pain management.

Innocan Pharma's Innovative CBD Technology Captivates Audience at PAINWeek Conference #USA #Las_Vegas #Innocan_Pharma #LPT-CBD #PAINWEEK

Thiard News@F4F

@newsen.bsky.social

7 months ago

Innocan Pharma Moves Forward with Share Consolidation for U.S. Offering Innocan Pharma Corporation announces a major step in its strategy by consolidating shares to facilitate its U.S. public offering and NASDAQ listing. This move reflects the company's ongoing growth plans.

Innocan Pharma Moves Forward with Share Consolidation for U.S. Offering #None #NASDAQ #Innocan_Pharma #Share_Consolidation

Thiard News@F4F

@newsen.bsky.social

7 months ago

Innocan Pharma to Present Innovative Cannabidiol Research at PAINWeek 2025 in Las Vegas Innocan Pharma will showcase groundbreaking findings on LPT-CBD at PAINWeek 2025, highlighting its potential in chronic pain management as a non-opioid solution.

Innocan Pharma to Present Innovative Cannabidiol Research at PAINWeek 2025 in Las Vegas #USA #Las_Vegas #Innocan_Pharma #LPT-CBD #PAINWeek_2025

Thiard News@F4F

@newsen.bsky.social

8 months ago

Innocan Pharma Makes Major Leap with U.S. Public Offering Registration Statement Innocan Pharma has officially filed a registration statement for a proposed public offering in the U.S., marking a pivotal step in its growth strategy.

Innocan Pharma Makes Major Leap with U.S. Public Offering Registration Statement #USA #NASDAQ #Calgary #Innocan_Pharma #IPO

Thiard News@F4F

@newsen.bsky.social

9 months ago

Innocan Pharma's Narrative Review on Synthetic Cannabidiol to be Presented at PAINWEEK 2025 Innocan Pharma will present findings on long-acting synthetic cannabidiol for chronic pain at PAINWEEK 2025, highlighting its potential as an alternative to opioids.

Innocan Pharma's Narrative Review on Synthetic Cannabidiol to be Presented at PAINWEEK 2025 #USA #Las_Vegas #Innocan_Pharma #CBD #PAINWEEK

Thiard News@F4F

@newsen.bsky.social

10 months ago

Innocan Pharma's Breakthrough Review on Synthetic CBD for Chronic Pain Innocan Pharma announces a peer-reviewed review highlighting liposomal synthetic CBD's potential to treat chronic pain as a non-opioid analgesic.

Innocan Pharma's Breakthrough Review on Synthetic CBD for Chronic Pain #USA #Innocan_Pharma #Chronic_Pain #CBD #Herzliya

Thiard News@F4F

@newsen.bsky.social

10 months ago

Innocan Pharma Reports Promising Q1 2025 Results with Revenue Growth and Strategic Developments Innocan Pharma Corporation announces significant revenue growth of 15% in Q1 2025, alongside innovative developments in drug delivery technology and expanded markets.

Innocan Pharma Reports Promising Q1 2025 Results with Revenue Growth and Strategic Developments #USA #Innocan_Pharma #LPT-CBD #Herzliya #BI_Sky_Global

Thiard News@F4F

@newsen.bsky.social

11 months ago

Innocan Pharma Secures First Patent in Mexico for Innovative Topical Pain Relief Solution Innocan Pharma announces its first patent approval in Mexico for a cannabis-based topical pain relief product, marking a significant milestone.

Innocan Pharma Secures First Patent in Mexico for Innovative Topical Pain Relief Solution #Cannabis #Mexico #Innocan_Pharma #Herzliya #Pain_Relief

Thiard News@F4F

@newsen.bsky.social

11 months ago

Innocan Pharma Successfully Completes Private Placement Offering for Innovative Cannabis Solutions Innocan Pharma announces the successful closure of its private placement, raising funds to enhance its cannabis-based pharmaceutical developments and consumer wellness products.

Innocan Pharma Successfully Completes Private Placement Offering for Innovative Cannabis Solutions #Canada #Calgary #pharmaceuticals #Innocan_Pharma #CBD_Technology

Thiard News@F4F

@newsen.bsky.social

1 year ago

Innocan Pharma Expands Its CBD Injection Patent Coverage and Announces New Funding Innocan Pharma is enhancing its IP protection for its CBD injection technology across Asia while announcing a private placement to boost capital.

Innocan Pharma Expands Its CBD Injection Patent Coverage and Announces New Funding #None #Innocan_Pharma #Intellectual_Property #CBD_Injection_Technology

Thiard News@F4F

@newsen.bsky.social

1 year ago

Innocan Pharma Achieves Record Revenue Growth in 2024 with Expansion in Product Offerings Innocan Pharma reports an impressive revenue growth for 2024, reaching $29.4 million, driven by strong demand and innovative products in the wellness sector.

Innocan Pharma Achieves Record Revenue Growth in 2024 with Expansion in Product Offerings #Canada #Calgary #Innocan_Pharma #BI_Sky_Global #CBD_Products

Thiard News@F4F

@newsen.bsky.social

1 year ago

Innocan Pharma Concludes Significant Debenture Unit Offering with Tamar Innovest Limited Innocan Pharma has finalized a $1 million debenture unit offering to its primary shareholder, Tamar Innovest, enhancing its funding and growth prospects.

Innocan Pharma Concludes Significant Debenture Unit Offering with Tamar Innovest Limited #Canada #Calgary #Innocan_Pharma #Tamar_Innovest #Debenture_Offering

Thiard News@F4F

@newsen.bsky.social

1 year ago

Innocan Pharma Seeks $1 Million from Tamar Innovest via Debenture Unit Offering Innocan Pharma Corporation has announced a private placement of a debenture unit targeting Tamar Innovest, aiming to raise $1 million for corporate needs.

Innocan Pharma Seeks $1 Million from Tamar Innovest via Debenture Unit Offering #Canada #Calgary #Innocan_Pharma #Tamar_Innovest #Debenture_Offering

Thiard News@F4F

@newsen.bsky.social

1 year ago

Innocan Pharma Achieves Patent Success in India for Its Innovative CBD Injection Technology Innocan Pharma has received its first Indian patent for a groundbreaking Liposomal CBD injection, paving the way for innovative chronic pain solutions.

Innocan Pharma Achieves Patent Success in India for Its Innovative CBD Injection Technology #India #Innocan_Pharma #Cannabinoids #Herzliya #Liposomal_CBD